Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/7096
Full metadata record
DC FieldValueLanguage
dc.contributor.authorÖzdel, O.-
dc.contributor.authorTümkaya, S.-
dc.contributor.authorKaradag, F.-
dc.contributor.authorCura, Ç.-
dc.date.accessioned2019-08-16T12:15:34Z-
dc.date.available2019-08-16T12:15:34Z-
dc.date.issued2008-
dc.identifier.issn1017-7833-
dc.identifier.urihttps://hdl.handle.net/11499/7096-
dc.description.abstractThe fact that health policies in developing countries make easy to get drugs, which should only be used under control, might result in dependence problems despite initial treatment purposes for drug intake. Benzodiazepines are drugs that have been widely prescribed and have been classified as controlled drugs. In this work, a case is described who began to use lorazepam, developed tolerance and dependence to mega-dose of drug because of easy access to drug. The patient has used lorazepam approximately for six months as he gradually increased dose to 220 mg/day. His efforts to drop the drug was unsuccessful and subsequently he applied to emergency service because of disturbing withdrawal symptoms. He showed initial withdrawal symptoms of severe restlessness, hyperpnoea, sweating, headache, anxiety, irritability which were succesfully controlled in the second day. Seizure or any other life threatening adverse effect were not observed during treatment. The health policies in developing countries should be arranged strictly to control access to controlled drugs even by prescribed patients in order to avoid development of addiction in such cases.en_US
dc.language.isotren_US
dc.relation.ispartofKlinik Psikofarmakoloji Bultenien_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAddictionen_US
dc.subjectBenzodiazepineen_US
dc.subjectPsychopathologyen_US
dc.subjectWithdrawalen_US
dc.subjectlorazepamen_US
dc.subjectarticleen_US
dc.subjectcase reporten_US
dc.subjectclinical featureen_US
dc.subjectdisease severityen_US
dc.subjectdrug dependenceen_US
dc.subjectdrug tolerabilityen_US
dc.subjectemergency health serviceen_US
dc.subjecthumanen_US
dc.subjectwithdrawal syndromeen_US
dc.titleMega-dose lorazepam addiction and withdrawal symptomsen_US
dc.typeArticleen_US
dc.identifier.volume18en_US
dc.identifier.issue2en_US
dc.identifier.startpage119
dc.identifier.startpage119en_US
dc.identifier.endpage121en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.scopus2-s2.0-46349092135en_US
dc.identifier.wosWOS:000258118600008en_US
local.message.claim2023-05-16T13:18:15.012+0300|||rp00008|||submit_approve|||dc_contributor_author|||None*
local.message.claim2023-05-16T13:18:17.297+0300|||rp00008|||submit_approve|||dc_contributor_author|||None*
local.message.claim2023-05-16T13:18:17.297+0300|||rp00008|||submit_approve|||dc_contributor_author|||None*
dc.identifier.scopusqualityQ3-
dc.ownerPamukkale University-
item.languageiso639-1tr-
item.openairetypeArticle-
item.grantfulltextopen-
item.cerifentitytypePublications-
item.fulltextWith Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.dept14.02. Internal Medicine-
crisitem.author.dept14.02. Internal Medicine-
Appears in Collections:Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Tıp Fakültesi Koleksiyonu
TR Dizin İndeksli Yayınlar Koleksiyonu / TR Dizin Indexed Publications Collection
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection
Files in This Item:
File SizeFormat 
ed870dc9-97ea-4fa7-a60d-ccb22eddd4ff.pdf40.77 kBAdobe PDFView/Open
Show simple item record



CORE Recommender

SCOPUSTM   
Citations

1
checked on Jun 29, 2024

WEB OF SCIENCETM
Citations

1
checked on Jul 2, 2024

Page view(s)

46
checked on May 27, 2024

Download(s)

40
checked on May 27, 2024

Google ScholarTM

Check





Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.